Viruses (Jan 2023)

Reduced Seasonal Coronavirus Antibody Responses in Children Following COVID-19 Mitigation Measures, The Netherlands

  • Reina S. Sikkema,
  • Erwin de Bruin,
  • Christian Ramakers,
  • Robbert Bentvelsen,
  • Wentao Li,
  • Berend-Jan Bosch,
  • Brenda Westerhuis,
  • Bart Haagmans,
  • Marion P. G. Koopmans,
  • Pieter L. A. Fraaij

DOI
https://doi.org/10.3390/v15010212
Journal volume & issue
Vol. 15, no. 1
p. 212

Abstract

Read online

SARS-CoV-2 prevention and control measures did not only impact SARS-CoV-2 circulation, but also the timing and prevalence of other seasonal respiratory viruses. Especially in children, information on exposure and infections to seasonal coronaviruses as well as SARS-CoV-2 in the first year of the pandemic is largely lacking. Therefore, we set up a one-year serological survey in a large tertiary hospital in the Netherlands. We show that seasonal coronavirus seroprevalence significantly decreased in 2021 in children less than one year, most likely due to COVID-19 control measures. The SARS-CoV-2 seroprevalence in children and adolescents increased from 0.4% to 11.3%, the highest in adolescents. This implies higher exposure rates in adolescents as compared to the general population (>18 years old). It is clear that there have been significant changes in the circulation and subsequent immunity against most respiratory pathogens as a result of the mitigation measures. The implications on shorter as well as longer term are still largely unknown, but the impact of the SARS-CoV-2 pandemic and subsequent control measures will continue to affect the dynamics of other pathogens.

Keywords